The incidence of post-keratoplasty glaucoma remains at about 30% of all grafts performed.
In the days before the introduction of the operating microscope and atraumatic fine gauge sutures, wound leaks were common after penetrating keratoplasty. Eyes which survived the first few days often had anterior synerchiae, both peripherally in the angle of the anterior chamber and also more centrally to the graft host interface. A frequent consequence was intractable glaucoma. Microsurgery rectified many of the peroperative technical problems. The problem of glaucoma, developing following keratoplasty, did not cease, however, nor did it abate. Irvingl in 1969, drew attention to the problem and the difficulties en countered in the assessment of raised intraocular pressure in many of these patients with corneal grafts. Applanation tonometry may be difficult because of severe astigmatism in the early (or even late) post-operative period, and also when the graft is 7 -7.5 mm in diameter, a size which causes the fluorescein meniscus or tonometer mires to be thick and inaccurate. Large degrees of astigmatism cause the mires to be distorted. The Mackay-Marg tonometer has been recommended but has failed to find widespread use, perhaps due to the difficulty in interpreting the tracing. (Fig. 1) If pressure readings can be difficult, then recording of the visual field, is even more so.
Susceptible patients (vide infra) are frequently aphakic, and this taken together with the swinging astigmatism may render field recording significantly inaccurate so that comparisons from one date to another may be invalid. Disc assessment too is inaccurate for regular monitoring since it will only reveal gross changes. Photogrammetry of the optic disc is an exciting prospect for the near future. Work is also in progress studying electrophysiological parameters in the detection of nerve fibre loss.2
Post-keratoplasty glaucoma (PKPG) is thus amongst the most difficult of the glaucomas to monitor. In addition to the damage that the raised lOP may do to the optic nerve, prolonged elevation of the lOP may be damaging to donor endo thelium.3 This review seeks to describe the significance of the problem of PKPG in corneal graft surgery, and to discuss the means of dealing with it.
Mechanisms
The major group of patients in whom pressure problems are encountered throughout the history of modern corneal grafting remains those with aphakic bullous keratopathy, and it is towards this group that most effort has been directed in order to understand the mechanisms involved. Arguing that the pressure rise found in aphakic grafts related to the change in geometry of the anterior chamber, Olson and Kaufman4 suggested, that with appropriate manipulation of the host and donor button sizes, it might be possible to avoid PKPG altogether. There followed a series of papers exploring these mechanisms. Zimmerman and co-workers using perfusion studies on cadaver eyes demonstrated that a corneal graft performed on a phakic eye did not appreciably alter the outflow facility when the host bed and donor were trephined to the same size, but in aphakic eyes the outflow facility was reduced by an average of 37 % , when midstromal suturing was employed, and not when through and through suturing was used. 5 The donor button size was also thought to be important and Zimmerman produced evidence to suggest that, in the aphakic patient, at least, the use of a donor button trephined with a trephine 0.5 mm larger than that used for the host bed reduced the incidence of PKPG. The effect was more obvious when a 7.5 mm trephine was used.6 Unfortunately, no account was taken of the real difference in size of excised buttons which may be produced by a change in intraocular pressure of the eye, or different pressures used when trephining or the differences which may be encountered due to varying corneal rigidity. It is quite possible to produce a corneal button at least 1 mm in diameter larger than the nominal trephine size by altering these parameters (personal observation) .
Olson and Kaufmann produced an elegant mathematical model demonstrating, theoretically, how outflow facility could be decreased follow ing keratoplasty.7,8 They suggested that the im portant adverse factors were tight suturing, long bites of the individual sutures, "Larger trephine sizes" (8.5 donor into 8 mm host bed), graft-host disparity when the donor is smaller than the host, and increased peripheral corneal thickness, To fit the observed situation that it was only the aphakic eye that suffered, they invoked the concept, first propounded by Zimmerman,5 of trabecular col lapse. The trabecular system was postulated to re quire the posterior fixation normally associated with an intact lens-ciliary body system. In aphakia the trabeculum relaxes and when the angle is com pressed following grafting the outflow is compro mised. Although this description fitted the recognised factors rather well, it is almost certain ly an over-simplification but the principles that were implied are worthy of consideration.
Observation of patients over the extended post operative period demonstrated that not all the lOP rise is temporarily directly related to the peri operative period. In these patients some additional or different mechanism must be involved. Lass suggested that PKPG could be associated with the development of fine peripheral anterior synechiae after keratoplasty.9 This may be progressive and has been the rationale for iris suturing during keratoplasty to limit synechial formation. 10 While synechial formation is also appealing as a descrip tion of the mechanism, it cannot explain all PKPG but in combination with Olson and Zimmerman's ideas, it may explain a great many situations. It is disappointing that after such elegant theoretical work there was so little clinical substantiation. Only one retrospective series lends support to these theories. Bournell found, in the short term, that oversized (by nominal trephine size) buttons produced better "control" than same size buttons in eyes with no pre-keratoplasty glaucoma. Where there was pre-existing glaucoma, then button size did not appear to have significant influence. In a similar study Perll2 was unable to demonstrate any protection against the development of glaucoma by using a donor cut with a trephine 0.5 mm larger than the host bed. Again this study was based on trephine size and not the size of the excised tissue. Olson 13 emphasised this point in the discussion of Perl's paperl2 and at the same time pointed out that analysis of Perl's figures did show differences between those who had the same size graft and those who had a slightly larger one, claiming that there was some protective role for the larger graft.
As corneal surgical techniques advance, and more and more severely disorganised eyes are salvaged, then it is likely that glaucoma will become a more common problem. Kirknessl4 has recently reported a series of patients undergoing keratoplasty following suppurative keratitis, per- Others (all small sample size) 16 6 37.5
HSK=herpes simplex keratitis, IK=interstitial keratitis, PK=penetrating keratoplasty foration being the main indication for surgery in 14 out of 23 eyes. There is a suggestion that the longer the eye was perforated before surgery, the greater was the likelihood of significant angle damage either from the development of peripheral anterior synechiae or from the associated severe intraocular inflammation. Nearly one third of all patients in the series (7/23) developed raised lOP requiring treatment, following keratoplasty. In a similar series of emergency grafts, but where there was no suppuration, four out of 13 perforations were associated with PKPG. (Unpublished data). Again there was a trend suggesting that the longer the interval between perforation and kerato plasty, the greater was the risk of glaucoma, although the numbers are too small to produce valid statistical significance. In most commentaries on PKPG, suggestions are made that manipulation of steroid therapy may help reduce intraocular pressure. 15 In fact, patients who have had corneal grafts generally need steroids as prophylaxis against graft rejec tion and also to treat postoperative inflamm ation. Steroid reduction or withdrawal is not a realistic management option in the majority of these cases.
Incidence
Since the work of Zimmerman, Olson and Kauf man, 1,4-8 there has been little description of the incidence of PKPG. It is not known whether modern intraocular techniques have helped alleviate the problem or whether more advanced surgery has brought more patients into the "at risk areas".
The authors retrospectively surveyed a series of patients attending the Corneal Clinic at Moor fields Eye Hospital who had undergone pene trating keratoplasty between 1978-85; a minimum follow-up of 12 months, with regular assessment was required. Patients who were lost to follow-up or returned to another (referring) ophthalmologist were excluded. With these exclu sions 305 patients were identified. Although great care was taken in the accurate assessment of donor button and host bed size, during keratoplasty, there was no deliberate policy of routinely oversizing trephines used for aphakic grafts. The majority of donors were moist chamber stored. Glaucoma was defined as intraocular pressure greater than 2lmmHg with or without evidence of disc cupping or field loss. Ages ranged from 1-89 yrs at the time of surgery. The overall break down of diagnosis and raised pressure is shown in Ta ble I. Data were analysed by Chi squared test in the case of the 3 binominal sample and the Chi squared test with Yates' correction when the data could be arranged in 2x2 contingency tables.
Only 5 % of all eyes had raised lOP that responded to manipulation of steroid therapy. All of these cases were among the 10 % that developed glaucoma more than 2 months postoperatively. It is interesting to note that Krupin and Waltman found that 6 % of the popUlation develop raised lOP after 6 weeks of topical thera py . 1 6 Overall, 91 eyes, 30 %, were found to have raised pressure (>2lmmHg). Eighty eyes were or became aphakic. (Table II) . There was a significantly higher in cidence of glaucoma in aphakic or pseudophakic patients compared to phakic, p < 0.00l. There was no significant difference between aphakic and pseudophakic patients and they will not be dif ferentiated further and both groups will be refer red to as aphakic. There were, however, too few patients in the group who had had posterior chamber lens implants inserted to allow differen tiation between this group and other cases of pseudophakia.
Overall, in the younger age group « 45 yrs), 18 % developed raised lOP, whereas 44 % of those over 45 years did so. Comparing the phakic and aphakic patients, in the aphakic group, 57 % of the younger and 49 % of the older groups developed raised pressure; but of the phakic sub division, 14 % of the younger and 36 % of the older groups had raised lOP. (Table III) . There was a significantly higher incidence of pressure prob lems in the younger group that had had lens surgery compared to those who had not, p<0.OO2. In the older group the difference was not significant p>O.l. There was, however, a significantly higher incidence of raised lOP in the older group of phakic patients compared to the younger phakic group, p>O.OOl.
Two other groups appeared to be at risk. In those undergoing keratoplasty for trauma the in cidence was significantly higher at p = 0.05, than others and in the group undergoing repeat corneal grafts compared to first grafts, p = 0.05. These data support the statements of Kaufman and others that aphakia presents a higher risk of PKPG, but the risk of developing PKPG after traumatic keratoplasty, and regraft has not received wide comment. The risk in old age may represent an association with decreased outflow of the eye and increased risk of glaucoma in the general popula- tion with age,I7 and its susceptibility to angle distortion. The incidence of steroid responders is very close to that of the general population but it is possible that more are concealed in the groups of patients in whom it was not possible to alter the topical steroid regimes. Thirty eyes in the study had some degree of pressure elevation which had been controlled, prior to surgery. Of these, the majority (60 %) required more therapy, or surgery, eventually, in 3 cases, but, paradoxically 3 cases required less therapy than had been needed pre-operatively. The incidence of PKPG seems remarkably con stant compared to that of a decade earlier although there appears to be a widening range of pre disposing factors. It will be interesting to observe in the near future whether the use of posterior chamber intraocular lens implants has any in fluence on the incidence of glaucoma in patients subsequently undergoing keratoplasty.
Management of Established Postkeratoplasty

Glaucoma
Medical
The mainstay of medical control of PKPG has traditionally been acetazolamide partly because of its efficacy and partly because it is taken systemically and therefore obviates the risk of toxicity from all topical applications to the graft epithelium. More recently the use of beta-blockers such as timolol have become more widespread, although it has been noted that there is often associated punctate epitheliopathy in the graft epithelium following their use.I8 Pilocarpine or phospho line iodide may be used with caution but are less likely to produce beneficial reduction of lOP in eyes which have extensive secondary angle closure. Miotics may also occasionally promote a low grade anterior segment inflamm ation which may promote allograft rejection episodes. Neutral adrenaline or dipivefrin are to be avoided in the susceptible groups because of the risks of cystoid macular oedema in aphakes and the danger of herpetic recrudescence in herpes simplex keratitis.
Surgical
Van Meter et al have recently described, for the first time, the use of laser trabeculoplasty (LTP) in PKPG. 19 Although the series is relatively small they were able to make useful comments. The patients were either aphakic or pseudophakic, and nine had had intracapsular lens extraction. Most of the eyes had extensive peripheral anterior synechiae thus limiting the availability of angle for LTP. Nevertheless a reduction in intracular pressure was achievable in eight of the 10 patients but in seven of the 10 patients it was not possible to reduce antiglaucoma medication.
The technique appears to be safe as far as the graft endothelium is concerned and merits con sideration early in the management of PKPG, and where there is not widespread secondary angle closure. No data exist on the success of trabeculec tomy in keratoplasty. In general terms, it might be expected that, where the conjunctiva was not scarred, then the success should be no worse than in a similar non-grafted eye. That may, however, be an oversimplification of the situation. Anec dotal experience of many surgeons is that trabeculectomy is a far from satisfactory techni que to use. If one considers, however, the nature of the groups at risk (viz aphakia, trauma, post suppurative keratitis), it is clear that many have extensive anterior segment disorganisation in cluding scarred conjunctivae, situations where trabeculectomy might be expected to do badly in any case. The surgical alternatives once trabeculectomy has failed are limited. Trabeculec tomy may be repeated but with rapidly diminishing prospects of success. Cylodialysis has been shown by Casey20 to have a limited chance of success. At the very best only 22 out of 100 cases were within a broad definition of success. Cyclocryotherapy has been used as the surgical procedure of choice in different and advanced cases. Binder21 showed that it could be useful, but his series had a relatively short follow-up of 20 months and he does not state the length of time that the patients were successfully controlled. In addition, there were a large number of serious complications including failed grafts, cyclitic membranes, cystoid macular oedema, vitreous haemorrhage and phthisis bulbi. The technique, nevertheless, was widely used. Perhaps the fact that it is not an intraocular procedure, helped en courage its use. Lemp22 had previously shown a high failure of grafts after any form of intraocular surgery. The rationale behind cyclocryotherapy is unsatisfactory. It seems illogical to treat a condi tion where the basic mechanism is an obstruction to the overflow, by reducing the inflow. Moreover, the method of applying a cryoprobe to the con junctival surface and freezing for 60 seconds without a thermocouple is crude, uncontrolled and likely to give unpredictable results.
Kirkness22 reviewed a small series of patients with advanced PKPG, managed with cycloabla tion using cryotherapy, who were all found to have a very poor result in the long term. Three out of 13 eyes had their pressure controlled for more than four years but none of these patients had clear grafts at the time of cyclocryotherapy. In the re mainder, all either failed to be controlled or developed such severe complications that vision was lost.
At the same time a series of patients with similar diagnoses and degree of advanced PKPG were presented in whom silicone drainage tubing had been used to control IOP.23 Silicone drainage tubing was first described by Molten024 in the management of advanced glaucoma after suc cessful animal experiments.25 Later Schocket26 modified Molteno's technique replacing the acrylic plate which is sited in the orbit with an inverted silicone gutter (such as is used in retinal detach ment surgery) encircling the eye. Schocket had used this method to control rubeotic glaucoma. Subsequently, with slight modifications, Molteno's and Schocket's designs have been used in the management of a variety of difficult glaucomas. [27] [28] [29] [30] One of the problems that was common no mat ter which technique was used was that prolonged hypotony and delayed expulsive haemorrhage were often found. Molteno modified his technique to a two stage process which was successful in reduc ing the incidence of these complications,31 but because of the relatively small surface area and consequently small surface area of fibrovascular sheath which developed around the plate, he was forced to use a complicated and potentially toxic anti fibrotic regime to limit the degree of fibrosis produced. Dense avascular fibrous tissue does not absorb the aqueous well. The surface area is much larger in Schocket's method and there is less need to limit the degree of fibrosis. K· k 32 Ir ness was the first to use a two-stage Schocket-type tubing and also the first to report the use of silicone drainage tubing in the manage ment of PKPG. He was able to demonstrate a mean pressure drop of at least 15 mmHg which was sustained for up to four years after tube in sertion (Fig 2) .23 The need for a protective mechanism against the complication of expulsive haemorrhage has been very ably demonstrated recently by Canning.33 This study found that ex pUlsive haemorrhage was particularly common after insertion of one-stage silicone tubes and in aphakic vitrectomised eyes. By preventing pro longed and profound hypotony the two-stage technique may help avoid this problem. The results from silicone drainage tubing are significantly superior to cyclocryotherapy in the management of advanced glaucoma once conventional drainage therapy has failed (p=O.05). Figure 3 shows the comparative survival curves for maintenance of normal lOP and graft status after either cyclocryo or silicone tube. The curves are constructed ac cording to the methods of Kaplan and Meier34 and represent the best means of following the suc cess of a treatment regime where recruitment of patients to a study begins at differing times and where follow-up varies, (censored data). Statistical comparisons can be made by using an analysis described by Gehan.35 Data quoted without such statistical elaboration is of limited value, when considering long-term effects of differing treat ment regimes. Following Kirkness'32 initial report, the use of a Molteno-type implant for PKPG has been reported by McDonne1l36 but with shorter follow-up. The pressure reducti o n achieved was similar to Kirkness' but the com plications produced were more frequent. In particular graft rejection was commonly � ncountered with five out of 17 eyes suffering ureversible rejection, presumably for the same reason as those in Kirkness' series. McDonnell's patients did not receive long term prophylactic topical steroid therapy. It is clear that the silicone drainage tubing can act as an additional limb of the graft rejection arc,37 presumably since the fibrovascular sheath which is in direct com munication with the anterior chamber does not have any blood-eye barrier. In addition, if the tube has been inserted through a cyclodialysis cleft, it may irritate the ciliary body producing a low grade uveitis which can also promote an allograft rejection. This emphasises the need for long term topical steroid therapy in grafted patients with silicone drainage tubes.
Conclusion
Postkeratoplasty glaucoma remains one of the most serious and difficult to manage complica-tions which may occur following penetrating keratoplasty. Prevention is difficult but avoidance of predisposing factors may help. Cataract inci sions through the clear cornea may limit conjunc tival scarring and angle damage, making control easier should PKPG develop in the aphakic or pseudophakic eye. Awareness of the susceptible groups, may allow more rigorous supervision so early diagnosis may be made and prolonged periods of raised pressure may be avoided. The use of oversized donor buttons may help and when there is no contra-indication, some benefit may be gained. A reliable and effective nonsteroidal immunsup presive in topical form does not as yet exist although cyclosporin A has shown early promise. Such a development will help in the future and may make control easier in established PKPG. Refinements of surgical technique may make surgical measures to control the pressure more reliable. Appreciation of the relative risks and merits of the various forms of surgery available may permit survival of vision for longer in severely compromised eyes. .
For the foreseeable future any surgeon under taking corneal graft surgery must be prepared to cope with the problem of raised intraocular pressure in a sizeable proportion of his patients.
